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Functional foods could differently affect human health in relation to the gender.
Recent studies have highlighted the anti-Candida and anti-Chlamydia activities of some
Lactobacillus strains isolated from the vagina of healthy women. Considering these
important beneficial activities on women’s health, the preparation of functional food
containing active vaginal lactobacilli can represent a great scientific challenge for the
female gender. In this context, the aim of this work was to study some functional and
technological properties of 17 vaginal strains belonging to the species Lactobacillus
crispatus, Lactobacillus gasseri, and Lactobacillus vaginalis in the perspective to include
them in dairy products. The antagonistic activities against the pathogenic and spoilage
species associated to food products and against the principal etiological agents of
the genitourinary tract infections were evaluated. Moreover, the vaginal lactobacilli were
characterized for their antibiotic resistance, and for their fermentation kinetics and viability
during the refrigerated storage in milk. Finally, the volatile molecule profiles of the obtained
fermented milks were determined. The results showed that several strains, mainly
belonging to the species Lactobacillus crispatus, exhibited a significant antagonistic
activity against spoilage and pathogenic microorganisms of food interest, as well as
against urogenital pathogens. All the vaginal lactobacilli showed antimicrobial activity
against strains belonging to the foodborne pathogenic species Listeria monocytogenes,
Listeria innocua, Eenterococcus faecalis and Escherichia coli. In addition, most of the
Lactobacillus strains were active toward the main pathogens responsible of vaginal
and urinary tract infections including Staphylococcus aureus, Enterococcus faecium,
Gardnerella vaginalis, and Proteus mirabilis. The antimicrobial activity can be attributed
to the high production of organic acids. The fermentation kinetics in milk indicated the
unsuitability of these lactobacilli as fermentation starters for the industrial production of
dairy products. However, some strains, belonging to the species Lactobacillus crispatus
and Lactobacillus gasseri, maintained a high viability in pasteurized milk at 4◦C for over
a month, showing their potential application as adjunct cultures for the production of
female gender foods. These data represent a first step for the set-up of a new functional
dairy product, directed to the women well-being, contributing also to innovate the dairy
sector.
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INTRODUCTION
Functional food is currently one of the fastest growing sector
of food industry because considers a dietary strategy to reduce
incidence of human illness (Gatti et al., 2004; Granato et al.,
2010; Lobo et al., 2010; Burns et al., 2015). The literature data
clearly indicate that functional foods could differently affect
human health in relation to the gender. In recent decades,
research on the female gender has been neglected, and the
results obtained in men have been directly translated to women
both in medicine and nutrition fields (Marino et al., 2011). The
European Commission’s Concerted Action on Functional Food
Science in Europe (FuFoSE), coordinated by the International
Life Science Institute (ILSI), defines functional foods as “products
having beneficial effects on one or more functions of the
human organism thus either improving the general and physical
conditions or/and decreasing the risk of the evolution of
diseases.” Moreover, this Institution states that “the amount
and form of functional foods must be compatible with the
nutritional parameters of a proper diet for the human organism.”
Therefore, probiotic foods have received a lot of attention,
because ingestion of probiotic cultures exerts beneficial effects on
the gastrointestinal and urogenital tracts (Barrons and Tassone,
2008; Ceapa et al., 2013).
Reproductive-aged women are often subjected to
gynecological disorders caused by vaginal microbiota dysbiosis
and the possible occurrence of vaginal infections, including
vulvovaginal candidiasis, bacterial vaginosis, aerobic vaginitis
and sexually transmitted diseases (Workowski and Berman, 2010;
Di Vito et al., 2015). Vulvovaginal candidiasis is a pathogenic
yeast infections (30–35% caused by Candida albicans) that
compromise the quality of life of women (das Neves et al., 2008).
Bacterial vaginosis is generally caused by an imbalance in the
ecology of the normal vaginal microbiota, characterized by a
decrease of Lactobacillus species, which predominate in the
vaginal microbiota of healthy women, and an increase in the
prevalence of anaerobic pathogenic bacteria (van de Wijgert
et al., 2014; Green et al., 2015; Machado and Cerca, 2015).
Aerobic vaginitis represents another of the major dismicrobisms
of the vaginal microbiota where lactobacilli are replaced with
aerobic organisms such as streptococci, enterococci, Escherichia
coli and Staphylococcus aureus (Han et al., 2014). Bacterial
vaginosis and aerobic vaginitis may negatively interfere with
women’s reproductive health, increasing the risk of sexually
transmitted infections, risk of abortion, preterm delivery,
premature rupture of membranes and chorioamnionitis (Geng
et al., 2016; Redelinghuys et al., 2016). Conventional therapies
used to treat these disorders are generally ineffective and
cause frequent relapses. On the contrary, the administration
of probiotics has resulted in a very effective strategy to restore
the normal vaginal microbiota (Borges et al., 2014). Beyond the
vaginal application, probiotic bacteria can be administered orally
thanks to their ability to pass from the intestine to the vagina,
with a consequent beneficial impact on the vaginal habitat, as
demonstrated by several investigations (Reid et al., 2001; Strus
et al., 2012; Vitali et al., 2012; Vujic et al., 2013; Heczko et al.,
2015).
Recent studies have highlighted the anti-Candida (Parolin
et al., 2015) and anti-Chlamydia (Nardini et al., 2016) activities
of some Lactobacillus strains isolated from the vagina of healthy
women. Considering these important beneficial activities on
women’s health, the preparation of functional food containing
active vaginal lactobacilli can represent a great scientific challenge
for the female gender. A wide literature indicates that dairy
products, such as fermentedmilks and cheese, represent excellent
carriers of probiotic bacteria, because they are characterized
by a high buffer capacity and a protective lipoprotein matrix.
These properties allow to better protect the microbial cells during
the gastrointestinal transit (Gomes da Cruz et al., 2009; Lollo
et al., 2013; Castro et al., 2015). Moreover, dairy products,
such as cheese and fermented milks, are perceived positively
by consumers because they represent a good source of calcium,
phosphorus and vitamins; therefore, the use of a cheese or a
fermented milk can be a strategy for the ingestion of probiotic
strains capable of positively influencing the healthy status of the
human vaginal microbiota, in order to protect the woman from
vaginal infections.
In this context, the aim of this work was to evaluate
the amensalistic properties and the technological potential
of 17 vaginal strains belonging to the species Lactobacillus
crispatus, Lactobacillus gasseri, and Lactobacillus vaginalis, in the
perspective to include them in dairy products. In particular,
these lactobacilli were evaluated for their antagonistic activity
against the pathogenic and spoilage species frequently associated
to food products and against the principal etiological agents
of bacterial vaginosis, aerobic vaginitis and urinary tract
infections. Moreover, the 17 strains were characterized for their
bacteriocin production and antibiotic susceptibility. Finally, the
fermentation kinetics and viability of these lactobacilli during
the refrigerated storage in milk were characterized, as well as the
volatile molecule profiles of the obtained fermented milks.
MATERIALS AND METHODS
Microbial Strains and Growth Conditions
Seventeen Lactobacillus (L.) strains were considered in this work
(Collection of the Department of Pharmacy and Biotechnology of
Bologna University). These lactobacilli were previously isolated
from vaginal swabs obtained from pre-menopausal Caucasian
women (aged 18–45 years old), who have no symptoms
of vaginal or urinary tract infection (Ethics Committee of
the University of Bologna: 52/2014/U/Tess) (Parolin et al.,
2015). They belong to three species highly represented in
the vaginal habitat: L. crispatus (BC1-BC8), L. gasseri (BC9-
BC14) and L. vaginalis (BC15-BC17). The strains Listeria
monocytogenes ATCC 13932 and Scott A, Listeria innocua
DSM 20649, Enterococcus faecalis ATCC 29212, EF37, and
BC101, Enterococcus faecium BC104, Escherichia coli DSM
18039, 555, and ATCC 11105, Staphylococcus aureus ATCC
29213 and DSM 20231, Lactobacillus plantarum V7B3, Bacillus
cereus ATCC 11966, Salmonella enteritidis E5, Enterococcus
faecium BC105, Gardnerella vaginalis BC106, and Proteus
mirabilis ATCC 29906, used as target microorganisms for the
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determination of antagonistic activity, belong to the Department
of Agricultural and Food Sciences of Bologna University or to
the Department of Pharmacy and Biotechnology of Bologna
University.
L. gasseri, L. crispatus, and L. vaginalis strains were grown in de
Man, Rogosa and Sharpe (MRS) broth (Oxoid Ltd., Basingstoke,
UK) at 37◦C for 24 h in anaerobic conditions using 3.5 liter
anaerobic jars with AnaeroGen paper sachets (Oxoid Ltd.,
Basingstoke, UK). Pathogenic and spoilage strains were cultured
in Brain Heart Infusion (BHI) broth (Oxoid Ltd.) at 37◦C
for 24 h.
Evaluation of Antagonistic Activity and
Bacteriocin Production of Vaginal
Lactobacilli
To evaluate the ability of the vaginal lactobacilli to antagonize
the target strains reported in Section Microbial Strains and
Growth Conditions, the method of Schillinger and Lücke (1989)
was applied with some modifications. Five µl of the overnight
cultures of the vaginal lactobacilli were poured over the surface
of MRS plates (containing 1.2% of agar) and allowed to grow
under anaerobic conditions at 37◦C for 24 h. Then 0.1 mL
(corresponding to approximately 7 log CFU) of an overnight
culture of the target strain was inoculated into 10 mL of BHI
soft agar (containing 0.7% of agar) and poured on the plates
where the vaginal lactobacilli had grown. After an incubation
at 37◦C for 24 h, the plates were checked to evaluate the zone
of growth inhibition. The inhibition halos were measured from
the outer perimeter of the spots in four directions and the
average diameters was considered. The antagonistic activity was
expressed in relation to the observed diameter of inhibition: −,
No inhibition; +, Diameter between 1 and 3mm; ++, Diameter
between 3 and 6mm; + + +, Diameter between 6 and 10 mm;
++++, Diameter > 10mm.
For the evaluation of bacteriocins production the method
reported by Schillinger and Lücke (1989) with somemodification
was used, 24 h cultures of the vaginal lactobacilli were centrifuged
(4000 rpm for 5min) and the supernatants were heated at
98◦C for 5min or filtered with 0.20µm cellulose acetate filters.
The cell-free supernatants were neutralized to pH 6.5 by the
addition of 1N NaOH. Then, 10 mL of BHI soft agar inoculated
with 0.1mL of an overnight culture of the indicator strain (L.
monocytogenesATCC 13932, L. innocuaDSM 20649, E. coliDSM
18039 and S. aureus DSM 20231), were poured into petri plates.
After plates drying, 5µl of a cell-free Lactobacillus supernatant
were poured on the plate surface. The plates were incubated
at 37◦C for 24 h and subsequently examined to evaluate the
diameter of growth inhibition diameter.
Antibiotic Susceptibility
The antibiotic susceptibility of the vaginal lactobacilli was
determined using M.I.C.E. evaluator strips (Oxoid Ltd.,
Basingstoke, UK). The OD600 of 24 h lactobacilli cultures were
adjusted at 0.6, 100 uL of the cell culture (approximately 7 log
CFU/mL) were inoculated on MRS agar plates and streaked
over the entire surface of the plates. The inoculated plates
were dried for about 15 min and finally the M.I.C.E evaluators
strips were placed under sterile conditions at the center of
the plates. The plates were then incubated under anaerobic
conditions at 37◦C for 24 h and the results were read as
reported in Thermo ScientificTM OxoidTM M.I.C.EvaluatorTM
(M.I.C.E.TM) Strips Interpretation Guide. As control strain
the E. faecalis ATCC29212 was used. The tested antibiotics
and the relative ranges of concentrations are the followings:
Amoxycillin, 256-0.015 µg/mL; Ampicillin, 256-0.015µg/mL;
Ciprofloxacin, 32-0.002µg/mL; Clindamycin, 256-0.015µg/mL;
Erythromycin, 256-0.015 µg/mL; Gentamicin, 256-
0.015µg/mL; Levofloxacin, 32-0.002 µg/mL; Penicillin, G 32-
0.002µg/mL; Tetracycline, 256-0.015µg/mL and Vancomycin
256-0.015 µg/mL.
Fermentation Kinetics of Vaginal
Lactobacilli in Pasteurized Milk and
Viability at Refrigerated Storage
Overnight cultures of lactobacilli were inoculated at a
concentration of 6 to 7 log CFU/mL in 50mL of pasteurized
whole milk, previously heated at 105◦C for 7min. The inoculated
milk was incubated at 37◦C and the acidification kinetics were
assessed using a pH-meter basic 20 (CRIASON, Modena, Italy).
The growth of each strain in fermented milk was evaluated
by plate counting on MRS agar plates. The same protocol was
used to evaluate the acidification kinetics in milk enriched with
0.5% tryptone after pasteurization. To assess the viability of
lactobacilli in pasteurized milk in refrigeration conditions, the
inoculated milk was incubated at 4◦C. The viability of each
strain was evaluated by plate counting on MRS agar plates. Each
experiment was performed in triplicate.
Analysis of Aromatic Profile in Fermented
Milk
The flavor profiles of the vaginal lactobacilli were evaluated
after growth in pasteurized milk enriched with 0.5%
tryptone after pasteurization. The fermented milks were
collected after 48 h of incubation at 37◦C. The inoculum
level and growth conditions were the same reported in
Section Fermentation Kinetics of Vaginal Lactobacilli in
Pasteurized Milk and Viability at Refrigerated Storage. The
volatile molecule profile of the samples was determined by
means of solid phase microextraction technique combined
with gas chromatography and mass spectrometry (GC-
MS/SPME), according to the method proposed by Burns
et al. (2015). The compounds were identified by using
the Agilent HewlettePackard NIST 98 mass spectral
database.
RESULTS
Antagonistic Activity of Vaginal Lactobacilli
The antagonist activities of 17 vaginal strains belonging to the
species L. crispatus, L. gasseri, and L. vaginalis against pathogens
and spoilage microorganisms of food interest were evaluated.
All tested lactobacilli showed a remarkable inhibitory activity
against L. monocytogenes Scott A, L. innocua DSM 20649, E.
faecalis EF37 and E. coli DSM 18039 and 555 (Table 1). In
general, L. crispatus BC1, BC4, BC5, BC6, BC7, and BC8 showed
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the highest antagonistic activity. In fact, the majority of these
strains determined inhibition zones ranging between 6 and 10
mm toward L. monocytogenes Scott A, L. innocua DSM 20649,
E. coli DSM 18039, and 555. Moreover, they showed a good
antagonist activity, with inhibition zones ranging between 1
and 6 mm, against L. monocytogenes ATCC 13932, E. faecalis
ATCC 29212 and EF37, S. aureus DSM 20231, L. plantarum
V7B3, B. cereus ATCC 11966, and, although at a lesser extent,
against S. enteritidis E5. L. crispatus BC2 and BC3 and L.
gasseri BC9, BC10, BC11, BC12 and BC13 showed a good
antagonistic activity against L. monocytogenes ATCC 13932 and
Scott A, L. innocua DSM 20649, E. faecalis ATCC 29212 and
EF37, E. coli DSM 18039 and 555, S. aureus DSM 20231. L.
gasseri BC14, L. vaginalis BC15, BC16, and BC17 showed the
lowest antagonistic activity against all the target microorganisms
considered.
The majority of the vaginal lactobacilli showed antibacterial
activity also toward the main pathogens responsible of vaginal
and urinary tract infections (E. faecalis BC101, E. faecium BC104,
E. coliATCC 11105, S. aureusATCC 29213, E. faecium BC105,G.
vaginalis BC106, and P. mirabilis ATCC 29906). In particular, L.
crispatus BC1 and L. vaginalis BC15 were the most active strains
as their inhibition zones were greater than 6 mm for all the test
pathogens. Otherwise, the lowest inhibitory activity was elicited
by L. gasseri BC11 and BC12 and L. vaginalis BC16 which gave
zones of inhibition lower than 6mm and, in some cases, were not
active (Table 1).
None of the considered Lactobacillus strain was able to
produce bacteriocins active against L. monocytogenes, L. innocua,
S. aureus, and E. coli. Consequently, the antagonistic activity
previously observed was due to other mechanisms, such as
the production of organic acids. In fact, the pH values of
the lactobacilli supernatants ranged between 3.57 and 3.82
for all the L. crispatus strains, excepting for BC3. Even L.
gasseri BC11, BC12 and BC13 supernatants showed pH values
below 4.00 (range 3.68–3.80). L. gasseri BC9, BC10, and BC14,
and L. vaginalis strains showed a lower acidification of the
culture medium, with pH values higher than 4.00 (range
4.00–5.07).
Antibiotic Susceptibility of Vaginal
Lactobacilli
The antibiotic susceptibility of the vaginal lactobacilli with
respect to a wide spectrum of antibiotics is reported in
Table 2. The results evidenced that among all the considered
antibiotics, Amoxicillin, Ampicillin, Erythromycin, and
Penicillin G showed the highest bactericidal effect. The
only exception was represented by L. vaginalis BC15 which
resulted less susceptible to penicillin G with MIC equal to
16 µg/mL compared to all the other tested lactobacilli. L.
gasseri BC14, L. vaginalis BC15, BC16, and BC17 resulted less
susceptible to Vancomycin, and Tetracycline. In general,
all the considered lactobacilli, except for L. crispatus
BC3 and L. vaginalis BC17, showed low susceptibility to
Ciprofloxacin and Levofloxacin, with MICs greater than
32µg/mL. TA
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TABLE 2 | Evaluation of minimum inhibitory concentrations (MIC, µg/mL) of various antibiotics against vaginal lactobacilli.
Strain Amoxicillin Ampicillin Ciprofloxacin Clindamycin Erythromycin Gentamycin Levofloxacin Penicillin G Tetracycline Vancomycin
L. crispatus BC1 0.5 0.75 >32 1.5 0.5 28 >32 0.12 1 0.38
BC2 0.12 0.09 >32 2 0.5 32 >32 0.03 1.5 2
BC3 0.18 0.18 1.5 32 0.12 >256 2 0.75 0.38 2
BC4 0.09 0.25 >32 1 0.38 32 >32 0.9 1 0.5
BC5 0.5 0.75 >32 0.5 0.18 24 >32 0.18 1 0.38
BC6 0.5 0.75 >32 0.38 0.25 64 >32 0.12 1.5 0.5
BC7 0.75 0.75 >32 1.5 0.5 24 >32 0.18 1.5 0.38
BC8 0.38 0.5 >32 16 0.25 192 >32 0.09 2 1.75
L. gasseri BC9 0.25 0.18 >32 0.38 0.12 48 >32 0.06 1.75 1
BC10 0.09 0.09 >32 4 0.5 64 >32 0.06 0.5 3
BC11 0.18 0.12 >32 4 0.5 48 >32 0.03 0.75 3
BC12 0.03 0.06 >32 4 0.75 16 >32 0.015 0.75 3
BC13 0.12 0.38 >32 8 0.18 96 >32 0.06 0.75 2
BC14 0.12 0.18 >32 0.03 0.25 24 >32 0.25 2 128
L. vaginalis BC15 0.5 0.38 >32 3 0.75 8 >32 16 8 128
BC16 0.25 0.12 >32 3 0.75 4 >32 0.25 4 128
BC17 0.09 0.12 4 0.03 0.25 4 8 0.25 2 >256
The MIC values reported are the average of three replicates.
Fermentation Kinetics of Vaginal
Lactobacilli in Pasteurized Milk and
Viability during the Refrigerated Storage
To assess the technological potential of the vaginal lactobacilli
considered in this study, their fermentation kinetics in
pasteurized whole milk at 37◦C were investigated. The
results highlighted the limited technological aptitude of the
lactobacilli (Table 3). In fact, none of the strains was able
to acidify the milk to pH values below 5.0 in 53 h at 37◦C.
L. crispatus BC4 showed the faster fermentation kinetics
reaching pH value of 5.02 in 48 h. Also, a reduced growth
capability of the Lactobacillus strains in fermented milk was
observed (Table 4). The addition of 0.5% of tryptone to
the whole pasteurized milk permitted to L. crispatus BC1
and BC4, and L. gasseri BC12 to reach pH values below 5
within 22 h of incubation at 37◦C (Table 5). After 30 h of
incubation, also the milks inoculated with L. crispatus BC5,
BC6, BC7, and BC8 reached pH values below 5.0. Since such
fermentation times are not compatible with the industrial
protocols for the production of fermented milk, the potential
of these Lactobacillus strains as adjuncts in dairy product
was evaluated, studying their survival during the refrigerated
storage of the inoculated milks. The results showed that none
of the considered strains was able to grow at the adopted
conditions (Table 6). However, some strains, such as L.
crispatus BC2 and BC3, L. gasseri BC9 and BC12, and L.
vaginalis BC15, showed reduced viability losses compared to
the other tested strains. In fact, their viability reductions during
the 28-day storage at 4◦C was lower than 1.5 log CFU/mL,
while the other strains showed a reduction higher than 2 log
CFU/mL.
Volatile Molecule Profiles of Vaginal
Lactobacilli in Pasteurized Milk
The analysis of the volatile molecule profiles of milks inoculated
with the vaginal lactobacilli and collected after 48 h of incubation
at 37◦C evidenced the presence of molecules belonging to the
chemical classes of acids, ketones and alcohols. The relative
percentages of the detected molecules in relation to the strain
considered are reported in Table 7. The strains belonging to L.
crispatus and in a minor extent those belonging to L. gasseri
resulted characterized by high amount of acetic acid. The strains
belonging to L. crispatus showed relative percentages of acetic
acid ranging between 24.9 and 72.6%, while in case of L. gasseri
acetic acid ranged between 9.8 and 45.2%. The strains belonging
to L. vaginalis produced a limited amount of acids, including
acetic acid. In fact, relative percentages of acids ranged between
1.9 and 4.0%. The L. vaginalis strains showed the highest relative
percentages of ethanol, above 50% in case of BC16 and BC17
strains, and 20.5% for BC15. L. gasseri BC14 showed a relative
percentage of ethanol of 27.2% while all the other L. gasseri
strains showed relative percentages lower than 10%. Regarding L.
crispatus species, BC2 and BC3 strains were the highest producers
of ethanol, registering values of 24.5 and 16.6%, respectively.
The relative percentages of ketones resulted extremely variables
in relation to the strain inoculated. Only L. vaginalis BC15
showed high relative percentages of 2-butanone and acetoin.
Contrarily, the strains belonging to L gasseri showed high levels
of cyclopentanone and 2-heptanone. Finally, L. crispatus BC2
and BC3 evidenced the highest levels of acetone. The presence
of diacetyl was detected for all the considered L. vaginalis strains
and the strains BC4 and BC9. High relative percentages of acetoin
were detected for the strains L. vaginalis BC15 and L. gasseri BC9,
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TABLE 3 | Acidification Kinetics (expressed as decrease of pH values) of the vaginal lactobacilli in pasteurized whole milk in relation to the incubation
time in hours (t3–t53) at 37◦C.
Strain t3 t6 t9 t11 t14 t16 t20 t24 t27 t31 t34 t37 t42 t48 t53
L. crispatus BC1 6.56 6.51 6.32 6.28 6.10 5.85 5.81 5.77 5.74 5.67 5.58 5.29 5.28 5.17 5.16
BC2 6.58 6.53 6.44 6.37 6.21 6.13 6.20 6.11 5.99 5.78 5.69 5.61 5.55 5.45 5.38
BC3 6.61 6.53 6.36 6.30 6.21 6.08 6.13 6.11 6.16 6.15 6.13 6.02 6.14 6.01 5.95
BC4 6.57 6.40 6.25 6.22 6.02 5.87 5.77 5.60 5.60 5.51 5.44 5.31 5.25 5.02 5.00
BC5 6.57 6.54 6.44 6.35 6.16 6.04 5.87 5.79 5.76 5.64 5.53 5.30 5.26 5.14 5.13
BC6 6.56 6.50 6.36 6.31 6.06 5.95 5.79 5.72 5.68 5.59 5.51 5.27 5.25 5.10 5.09
BC7 6.55 6.49 6.34 6.27 6.10 6.01 5.84 5.67 5.68 5.60 5.50 5.31 5.30 5.13 5.13
BC8 6.56 6.48 6.39 6.32 6.26 6.25 6.21 6.20 6.25 6.24 6.03 5.91 6.21 6.16 6.28
L. gasseri BC9 6.59 6.53 6.47 6.39 6.36 6.34 6.30 6.24 6.28 6.31 6.24 6.12 6.23 6.15 6.26
BC10 6.59 6.52 6.41 6.34 6.23 6.21 6.09 6.07 6.05 6.02 6.02 5.76 5.68 5.80 5.83
BC11 6.55 6.51 6.43 6.36 6.18 6.05 5.89 5.78 5.77 5.63 5.45 5.33 5.26 5.05 5.01
BC12 6.62 6.54 6.37 6.32 6.23 6.09 6.11 6.07 6.04 6.01 5.97 5.94 5.92 5.88 5.82
BC13 6.56 6.50 6.39 6.33 6.24 6.13 6.02 5.91 5.84 5.79 5.68 5.45 5.36 5.24 5.19
BC14 6.63 6.55 6.39 6.31 6.24 6.11 6.07 6.02 5.98 5.94 5.89 5.84 5.77 5.71 5.65
L. vaginalis BC15 6.58 6.41 6.27 6.21 6.04 5.96 5.87 5.79 5.78 5.67 5.55 5.48 5.46 5.38 5.31
BC16 6.58 6.43 6.40 6.31 6.26 6.19 6.12 6.03 5.98 5.92 5.88 5.81 5.76 5.69 5.61
BC17 6.55 6.48 6.37 6.28 6.16 6.06 6.01 5.92 5.84 5.77 5.69 5.67 5.51 5.46 5.33
The pH values are the average of three replicates, the variability for all samples was always <5%.
BC13 and BC14. However, to a minor extend, the presence of
acetoin was detected also for the strains of L. crispatus BC1, BC2,
BC4, BC7, and BC8. Acetaldehyde was produced by the tested
strains in a range between 0.5 and 5.0 % except for the strains L.
vaginalis BC15-BC17 and the strains BC3, BC6, and BC14.
DISCUSSION
The administration of probiotics has been shown to be effective
in restoring a normal vaginal and gut microbiota, contributing
to resolve gynecological disorders (Borges et al., 2014). The
rationale behind the present work is to develop a functional food
for the female gender capable of delivering probiotic lactobacilli
in the vagina in order to promote the gynecological health
through nutrition. Taking an active ingredient through a food
is a form of administration that best meets the compliance of
the consumer and this aspect represents an important added
value of a functional food. In particular, the anti-Candida and
antibacterial activities of the Lactobacillus strains used in this
work can be exploited to restore the healthy status of the
human vaginal and gut microbiota, contributing to protect the
woman from vaginal dysbiosis and infections. However, the
formulation of a functional dairy product should be subordinate
to the selection of probiotic strains able to maintain viability and
functionality during storage and without negative effects on the
hedonistic properties of the carrier food. In fact, to exert positive
health effects, the functional microorganisms need to be viable,
active, and sufficiently abundant, in concentrations of at least
6 log CFU/g throughout the shelf life, and consequently they
have to maintain their viability during the refrigerated storage
(Tripathi and Giri, 2014; Burns et al., 2015).
TABLE 4 | Microbial viability of vaginal Lactobacillus strains inoculated in
pasteurized whole milk (log CFU/mL ± standard deviation) immediately
after inoculation (t0) and after 24h (t24) of incubation at 37◦C.
t0 t24
L. crispatus BC1 6.84 ± 0.23 8.06 ± 0.33
BC2 6.96 ± 0.18 7.75 ± 0.22
BC3 6.95 ± 0.21 7.87 ± 0.17
BC4 6.88 ± 0.33 7.97 ± 0.22
BC5 7.00 ± 0.18 7.95 ± 0.18
BC6 7.14 ± 0.26 8.01 ± 0.27
BC7 6.95 ± 0.31 8.21 ± 0.31
BC8 6.90 ± 0.24 7.38 ± 0.38
L. gasseri BC9 6.72 ± 0.33 7.79 ± 0.19
BC10 6.85 ± 0.17 8.05 ± 0.24
BC11 6.94 ± 0.25 8.23 ± 0.27
BC12 6.86 ± 0.27 8.02 ± 0.36
BC13 7.04 ± 0.19 8.11 ± 0.22
BC14 6.98 ± 0.34 7.86 ± 0.21
L. vaginalis BC15 6.89 ± 0.22 7.98 ± 0.33
BC16 6.78 ± 0.24 7.75 ± 0.34
BC17 7.01 ± 0.12 7.97 ± 0.28
The cell counts are the average of three replicates, the values are reported ± standard
deviations (SD).
Our data clearly indicated the unsuitability of the studied
strains as fermentation starters for the industrial production of
dairy products. In fact, the fermentation kinetics in pasteurized
whole milk have shown that none of the strains could acidify
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TABLE 6 | Microbial viability of vaginal Lactobacillus strains inoculated in pasteurized whole milk (log CFU/mL ± standard deviation) immediately after
inoculation (t0) and after 7 (t7), 14 (t14), 21 (t21), and 28 (t28) days of refrigerated storage at 4◦C.
Strain t0 t7 t14 t21 t28
L. crispatus BC1 6.93 ± 0.22 6.79 ± 0.22 6.31 ± 0.31 6.20 ± 0.28 5.77 ± 0.31
BC2 7.91 ± 0.33 7.60 ± 0.39 7.11 ± 0.39 7.27 ± 0.34 6.47 ± 0.28
BC3 8.13 ± 0.35 7.89 ± 0.33 7.92 ± 0.41 7.90 ± 0.41 7.82 ± 0.34
BC4 6.78 ± 0.21 5.54 ± 0.41 6.40 ± 0.24 6.29 ± 0.22 5.96 ± 0.18
BC5 6.60 ± 0.19 6.25 ± 0.31 5.63 ± 0.19 5.45 ± 0.36 4.75 ± 0.39
BC6 6.78 ± 0.28 6.19 ± 0.28 6.02 ± 0.25 5.81 ± 0.29 5.13 ± 0.41
BC7 7.23 ± 0.33 6.57 ± 0.33 6.15 ± 0.33 6.13 ± 0.31 5.68 ± 0.34
BC8 7.48 ± 0.31 3.90 ± 0.59 3.59 ± 0.24 2.78 ± 0.27 1.60 ± 0.69
L. gasseri BC9 7.18 ± 0.22 6.62 ± 0.29 6.58 ± 0.26 6.01 ± 0.36 6.10 ± 0.27
BC10 7.10 ± 0.28 6.27 ± 0.34 5.95 ± 0.33 5.36 ± 0.35 5.07 ± 028
BC11 7.20 ± 0.39 6.19 ± 0.24 5.82 ± 0.24 5.40 ± 0.29 5.18 ± 0.31
BC12 7.67 ± 0.24 6.92 ± 0.31 6.85 ± 0.19 6.57 ± 0.31 6.26 ± 0.41
BC13 7.00 ± 0.19 3.24 ± 0.36 3.16 ± 0.48 2.93 ± 0.47 2.43 ± 0.58
BC14 7.15 ± 0.22 5.51 ± 0.34 4.30 ± 0.54 3.81 ± 0.45 1.48 ± 0.38
L. vaginalis BC15 7.23 ± 0.36 6.84 ± 0.19 7.02 ± 0.28 6.74 ± 0.24 6.44 ± 0.28
BC16 7.28 ± 0.45 6.59 ± 0.38 6.29 ± 0.25 5.79 ± 0.38 5.34 ± 0.45
BC17 7.30 ± 0.21 7.04 ± 0.22 6.54 ± 0.17 5.28 ± 0.37 5.02 ± 0.33
The cell counts are the average of three replicates, the values are reported ± standard deviations (SD).
the milk to pH values below 5 in a considered time of 53 h at
the temperature of 37◦C. Even the addition of 0.5% tryptone,
to provide a source of protein and promote the growth kinetics
of the tested strains, did not increase the acidification rate to
acceptable levels for the dairy industries. Nevertheless, some
Lactobacillus strains maintained a high viability for over a month
in pasteurized whole milk at 4◦C, indicating their suitability in
dairy products as adjunct cultures instead of starters. This is
a very important result from an applicative point of view: the
use of vaginal lactobacilli as additional cultures in fermented
milks and fresh cheeses, which represent the most used carriers
for functional microorganisms, allows to overcome the typical
sensory defects of the products obtained using probiotics as
starters (Castro et al., 2015). Similarly, Patrignani et al. (2006)
reported, for the functional strains belonging to the species
L. gasseri, L. plantarum, L. rhamnosus isolated from Masaai
milks, slow fermentation kinetics, not acceptable for industrial
fermentation. In sight of this, the probiotic bacteria belonging to
Bifidobacterium spp. and the species L. acidophilus, L. casei, and
L. rhamnosus are generally used as additional cultures due to their
poor fermentation kinetics and the scarce sensory properties
of fermented milk obtained when they are used as starters
(Patrignani et al., 2007; Settanni and Moschetti, 2010; Castro
et al., 2015).
The data reported in this work showed that some Lactobacillus
strains could maintain a high viability for over a month in
pasteurized whole milk at 4◦C, indicating their suitability as
adjunct cultures in dairy products. This is a very important result
from an applicative point of view: the use of vaginal lactobacilli
as additional cultures in dairy products, such as fermented milks
and fresh cheeses, which represent the most used carriers for
functional microorganisms, allows to correct the typical sensory
defects of the products obtained using probiotics as starters
(Castro et al., 2015). On the other hand, to produce a satisfactory
fermented probiotic milk product, the viable cell count at the
time of consumption should be above 6 log CFU/g in order
to comply with the International Dairy Federation standards
(IDF 1992) and to ensure the supply of a sufficient “daily dose”
of viable bacteria (Patrignani et al., 2006, 2016). Consequently,
the most important criterion to select probiotic strains to be
employed in fermented milk products as adjuncts, is their ability
to maintain high viability during manufacture and refrigerated
storage (Kailasapathy and Chin, 2000; Soccol et al., 2010). In fact,
several cases of marked loss of viability of the most common
probiotics belonging to Bifidobacterium spp. and L. acidophilus
species in refrigerated dairy products have been reported in
literature (Patrignani et al., 2006).
In this work, we demonstrated that several vaginal
lactobacilli, mainly belonging to L. crispatus species, exhibited a
remarkable antagonistic activity against spoilage and pathogenic
microorganisms of food interest, as well as against urogenital
pathogens. In addition, previous literature data had clearly
indicated that the vaginal lactobacilli considered in this study,
especially L. crispatus strains, were characterized by significant
anti-Candida (Parolin et al., 2015) and anti-Chlamydia (Nardini
et al., 2016) activities. The results obtained in this research
showed the absence of bacteriocin production by all the tested
strains. The highest antagonistic activities of L. crispatus BC1,
BC4, BC5, and BC6 can be attributed to the highest production
of organic acids as demonstrated by the pH values of the cell free
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supernatants, and the volatile molecule profiles of the inoculated
milks registering the highest abundances of acetic acid and
short chain fatty acids (hexanoic and butanoic acid). The high
levels of acetic acid detected in the volatile molecule profiles
of the L. crispatus strains can explain their high antimicrobial
activities against the target microorganisms. In fact, it is well
reported that short-chain organic acids, such as acetic acid and
lactic acid, can exert a strong antimicrobial activity against
both gram-positive and gram-negative microorganisms, due
to the diffusion of the acids through the cell membrane of
microorganisms (Varalakshmi et al., 2014; Poppi et al., 2015).
Also Annuk et al. (2003) attributed the strong antimicrobial
activity of intestinal lactobacilli against both Gram-negative
and Gram-positive bacteria to the high production of organic
acids, such as lactic acid, succinic acid and acetic acid. Moreover,
Breshears et al. (2015) showed that high concentrations of
acetic acid could inhibit the growth of Neisseria gonorrhoeae
on porcine vaginal mucosal model at pH 5.5. In addition,
all the tested lactobacilli showed the production of diacetyl,
acetoin, and also acetaldehyde, which are important for the
sensory characterization of dairy products as well as for
their antimicrobial activity against both gram-positive and
gram-negative pathogenic species (Ott et al., 1997; Lanciotti
et al., 2003; Patrignani et al., 2007, 2016). Such molecules are
considered key factor for the characterization of dairy products
(Escamilla-Hurtado et al., 2000; Lanciotti et al., 2003, 2007).
Furthermore, the capacity to generate diacetyl and acetoin is
considered a general trait relevant for the selection of starter
lactic acid bacteria (Cruciata et al., 2014). Moreover, acetaldehyde
is considered a fundamental compound for fermented milks
quality as it gives a characteristic flavor in yogurt and fermented
milks (Smit et al., 2005; Patrignani et al., 2007). These results are
particularly important since the ability to impart good sensory
properties is an important selection criterion for starter cultures
or probiotic adjuncts (Patrignani et al., 2006; Cheng, 2010;
Routray and Mishra, 2011; Widyastuti and Febrisiantosa, 2014).
The determination of the antibiogram is considered a
prerequisite in protocols for the selection of starter, co-starter or
functional microorganisms by EFSA (Wedajo, 2015).
The antibiogram results are in agreement with literature
data (Ammor et al., 2007; Nueno-Palop and Narbad, 2011;
Fguiri et al., 2015). In fact, the lactobacilli showed a variable
spectrum of susceptibility in relation to the species and the
strain considered. The majority of the tested strains resulted
very sensitive to Amoxicillin, Ampicillin, Penicillin G and
Erythromycin. Some lactobacilli were found to be less susceptible
to different antibiotics. In these case, further studies are needed
to better characterize the resistance mechanism, before including
these strains in food products. Other authors have observed a
high susceptibility of different lactic acid bacteria strains to these
antibiotics (Danielsen and Wind, 2003; Temmerman et al., 2003;
Nueno-Palop and Narbad, 2011). In general, the spectrum of
susceptibility to antibiotics results variable in function of the
lactic acid bacteria strain considered. In fact, several studies have
shown the natural resistance of lactic acid bacteria to a wide range
of antibiotics (Botes et al., 2008; Fguiri et al., 2015).
Although strains belonging to L. casei (L. paracasei), L.
rhamnosus, and L. plantarum are widely used in probiotic
dairy products (Kaushik et al., 2009; Zheng et al., 2013), only
few reports are focused simultaneously on their functional and
technological properties (Olasupo et al., 2001; Patrignani et al.,
2006). Some aspects, i.e., viability in milk during refrigerated
storage, antagonistic activity against pathogenic and spoilage
species, volatile molecule profiles and production of key sensory
compounds such as dyacetyl, are particularly important for the
selection of adjunct cultures to produce dairy functional foods
since they are the main choice criteria for the consumers and
the dairy industries. L. crispatus BC1, BC2, BC3, BC4, and BC5,
L. gasseri BC9 and BC12, and L. vaginalis BC15 maintained a
high vitality during refrigerated storage and at the same time they
showed a good antimicrobial activity against both spoilage and
pathogenic microorganisms. In addition, they showed interesting
volatile molecule profiles, without negative aroma compounds
for dairy products. These strains, with proven anti-Candida
and antibacterial activities, appear to be the most promising
candidates to be used as adjunct cultures for the production of
a functional food capable of improving the health of the female
gender.
CONCLUSIONS
The results obtained represent a first towel for the selection
of adjunct cultures to produce new functional dairy products,
directed to the women well-being, contributing also to innovate
the dairy sector. In fact, in recent years there has been a significant
increasing demand for tailor made microbial strains able to
contribute to food innovation in terms of functionality, sensory,
nutritional and rheological characteristics. The present study has
identified a pool of strains having technological and functional
properties promising for the production of a dairy functional
food specifically directed to female gender.
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